Glaukos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. 

CEO
Thomas William Burns
CEOThomas William Burns
Employees
907
Employees907
Headquarters
Aliso Viejo, California
HeadquartersAliso Viejo, California
Founded
1998
Founded1998
Employees
907
Employees907

GKOS Key Statistics

Market cap
5.35B
Market cap5.35B
Price-Earnings ratio
-36.97
Price-Earnings ratio-36.97
Dividend yield
Dividend yield
Average volume
492.19K
Average volume492.19K
High today
$107.25
High today$107.25
Low today
$101.57
Low today$101.57
Open price
$105.73
Open price$105.73
Volume
507.24K
Volume507.24K
52 Week high
$108.22
52 Week high$108.22
52 Week low
$49.19
52 Week low$49.19

GKOS News

Benzinga 2d
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst

Loading... Loading... Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from $(0.59) a year ago, missing the consens...

Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
Yahoo Finance 3d
Glaukos Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Glaukos (GKOS) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.59 per shar...

Glaukos Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
TipRanks 3d
Glaukos First-Quarter 2024 Financial Performance Overview - TipRanks.com - TipRanks

Glaukos (GKOS) has shared an update. Glaukos Corporation has released its first-quarter financial summary for 2024, offering investors a glimpse into the compa...

Analyst ratings

67%

of 15 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

More GKOS News

TipRanks 3d
Glaukos reports Q1 EPS (70c), consensus (57c)

Reports Q1 revenue $85.6M, consensus $79.6M. “Our record first quarter results reflect successful global execution of our key strategic plans,” said Thomas Burn...

Yahoo Finance 3d
Glaukos Announces First Quarter 2024 Financial Results - Yahoo Finance

ALISO VIEJO, Calif., May 01, 2024--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on nov...

Glaukos Announces First Quarter 2024 Financial Results - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.